Milestone Pharmaceuticals Inc. Public Float
Milestone Pharmaceuticals Inc. (MIST) had Public Float of $98.90 million as of 2025-06-30, per its 10-K filed 2026-03-20.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-20
- 2025-06-30: Entity Public Float $98.90M.
- 2024-06-30: Entity Public Float $69.80M.
- 2023-06-30: Entity Public Float $95.90M.
- 2022-06-30: Entity Public Float $184.50M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $98.90M 10-K · filed 2026-03-20 |
| 2024-06-30 | $69.80M 10-K · filed 2025-03-13 |
| 2023-06-30 | $95.90M 10-K/A · filed 2024-04-29 |
| 2022-06-30 | $184.50M 10-K/A · filed 2023-05-31 |
| 2021-06-30 | $164.20M 10-K · filed 2022-03-24 |
| 2020-06-30 | $93.30M 10-K · filed 2021-03-29 |
| 2019-06-30 | $217.50M 10-K/A · filed 2020-10-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B |